Corpus ID: 51998758

Differentiating the Therapeutic uses of EPA and DHA in clinical practice October 2008

@inproceedings{2012DifferentiatingTT,
  title={Differentiating the Therapeutic uses of EPA and DHA in clinical practice October 2008},
  author={},
  year={2012}
}
  • Published 2012

References

SHOWING 1-10 OF 51 REFERENCES
Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.
  • 293
  • Highly Influential
The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans
  • T. Mori, R. Woodman
  • Biology, Medicine
  • Current opinion in clinical nutrition and metabolic care
  • 2006
  • 227
  • Highly Influential
  • PDF
The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition
  • Clin Exp Allergy
  • 2004
Blood levels of long-chain n-3 fatty acids and the risk of sudden death.
  • 1,151
  • Highly Influential
  • PDF
Fatty acid modulation of endothelial activation.
  • 473
  • Highly Influential
  • PDF
Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans.
  • 204
  • Highly Influential
  • PDF
Serum fatty acids and the risk of coronary heart disease.
  • 240
  • Highly Influential
  • PDF
Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation
  • 2008
Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
  • 40
  • PDF
...
1
2
3
4
5
...